There is no clear agreement on how to handle anticoagulation decisions before minimally invasive glaucoma surgery, according to a speaker at the American Glaucoma Society meeting.
Tejus Pradeep, MD, said the literature on anticoagulants in MIGS has been limited, and he and colleagues wanted to find out what glaucoma surgeons thought about the topic.
They created an online anonymized survey for AGS members using standard definitions of anticoagulants and antiplatelet agents, as well as six broad definitions of MIGS procedures.
Among the 103 surgeons who responded, the most commonly performed MIGS